Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Inventory Average (2016 - 2026)

Ocular Therapeutix has reported Inventory Average over the past 13 years, most recently at $3.7 million for Q1 2026.

  • For Q1 2026, Inventory Average rose 15.72% year-over-year to $3.7 million; the TTM value through Mar 2026 reached $3.7 million, up 15.72%, while the annual FY2025 figure was $3.3 million, 23.55% up from the prior year.
  • Inventory Average for Q1 2026 was $3.7 million at Ocular Therapeutix, up from $3.5 million in the prior quarter.
  • Over five years, Inventory Average peaked at $3.7 million in Q1 2026 and troughed at $1.3 million in Q1 2022.
  • A 5-year average of $2.5 million and a median of $2.4 million in 2024 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: surged 62.58% in 2023 and later grew 11.01% in 2024.
  • Year by year, Inventory Average stood at $1.8 million in 2022, then increased by 29.64% to $2.3 million in 2023, then rose by 19.36% to $2.7 million in 2024, then grew by 29.51% to $3.5 million in 2025, then increased by 3.53% to $3.7 million in 2026.
  • Business Quant data shows Inventory Average for OCUL at $3.7 million in Q1 2026, $3.5 million in Q4 2025, and $3.3 million in Q3 2025.